CRISPR-targeting introduced a G to A point mutation to produce the amino acid substitution of glutamic acid to lysine at position 167 (E167K). This mutation is analogous to the C to T variant (rs58542926-T) identified in human patients with cardiometabolic diseases. (J:314590)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count